PL3233174T3 - Wewnątrzgałkowe dostarczanie bioaktywnych cząsteczek za pomocą jontoforezy - Google Patents
Wewnątrzgałkowe dostarczanie bioaktywnych cząsteczek za pomocą jontoforezyInfo
- Publication number
- PL3233174T3 PL3233174T3 PL15871275T PL15871275T PL3233174T3 PL 3233174 T3 PL3233174 T3 PL 3233174T3 PL 15871275 T PL15871275 T PL 15871275T PL 15871275 T PL15871275 T PL 15871275T PL 3233174 T3 PL3233174 T3 PL 3233174T3
- Authority
- PL
- Poland
- Prior art keywords
- iontophoresis
- bioactive molecules
- intraocular delivery
- intraocular
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/065—Diphenyl-substituted acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462094663P | 2014-12-19 | 2014-12-19 | |
PCT/US2015/067125 WO2016100972A2 (en) | 2014-12-19 | 2015-12-21 | Intraocular delivery of bioactive molecules using iontophoresis |
EP15871275.2A EP3233174B1 (en) | 2014-12-19 | 2015-12-21 | Intraocular delivery of bioactive molecules using iontophoresis |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3233174T3 true PL3233174T3 (pl) | 2021-08-30 |
Family
ID=56127887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15871275T PL3233174T3 (pl) | 2014-12-19 | 2015-12-21 | Wewnątrzgałkowe dostarczanie bioaktywnych cząsteczek za pomocą jontoforezy |
Country Status (9)
Country | Link |
---|---|
US (3) | US10327946B2 (pl) |
EP (1) | EP3233174B1 (pl) |
JP (2) | JP2017538728A (pl) |
CN (1) | CN107249678B (pl) |
BR (1) | BR112017012655B1 (pl) |
ES (1) | ES2874562T3 (pl) |
PL (1) | PL3233174T3 (pl) |
RU (1) | RU2706704C2 (pl) |
WO (1) | WO2016100972A2 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3014616A1 (en) * | 2016-02-15 | 2017-08-24 | Kemin Industries, Inc. | Water soluble lipophilic materials |
PL3416622T3 (pl) * | 2016-02-15 | 2023-09-11 | Kemin Industries, Inc. | Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych |
CN111346056B (zh) * | 2018-12-21 | 2021-10-22 | 江苏省农业科学院 | 一种α-葡萄糖基橙皮苷修饰叶黄素脂质体的制备方法 |
EP3908238A1 (en) | 2019-01-09 | 2021-11-17 | Twenty Twenty Therapeutics LLC | Eye mounted device for therapeutic agent release |
JP2022517762A (ja) | 2019-01-09 | 2022-03-10 | トゥウェンティ トゥウェンティ セラピューティクス エルエルシー | 眼球装着装置からのプログラム可能な治療剤送達 |
RU209086U1 (ru) * | 2021-10-25 | 2022-02-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) | Аппликатор глазной для лечения заболеваний глаз |
RU209085U1 (ru) * | 2021-10-25 | 2022-02-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) | Аппликатор глазной |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5000887A (en) * | 1988-05-17 | 1991-03-19 | Liposome Technology, Inc. | Preparation of uniform-size liposomes |
US5270051A (en) * | 1991-10-15 | 1993-12-14 | Harris Donald H | Enzyme-orthokeratology |
US20030181531A1 (en) * | 2003-02-11 | 2003-09-25 | David Sherris | Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
EP1547674A1 (en) * | 2003-12-23 | 2005-06-29 | MediGene Oncology GmbH | Method for producing colloidal nanoparticles |
US7794713B2 (en) * | 2004-04-07 | 2010-09-14 | Lpath, Inc. | Compositions and methods for the treatment and prevention of hyperproliferative diseases |
FR2869531B1 (fr) * | 2004-04-30 | 2006-07-14 | Optis France Sa Sa | Dispositif de iontophorese oculaire diminuant les irritations |
EP1768657B1 (en) * | 2004-06-23 | 2008-08-13 | Sirion Therapeutics, Inc. | Methods and compositions for treating ophthalmic conditions with retinyl derivates |
EP1655021B1 (en) * | 2004-11-09 | 2008-10-29 | Novagali Pharma SA | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
EA011154B1 (ru) * | 2004-12-08 | 2009-02-27 | Сирион Терапьютикс, Инк. | Композиции для лечения ретинол-ассоциированных заболеваний |
MX2007013760A (es) * | 2005-05-04 | 2008-01-28 | Noxxon Pharma Ag | Uso novedoso de spiegelmers. |
US8099162B2 (en) | 2005-11-29 | 2012-01-17 | Eyegate Pharma, S.A.S. | Ocular iontophoresis device |
US20070299386A1 (en) * | 2006-06-23 | 2007-12-27 | Minu, L.L.C. | Delivery of an ocular agent using iontophoresis |
WO2008006535A2 (en) | 2006-07-10 | 2008-01-17 | Medigene Ag | Use of a cationic colloidal preparation for the diagnosis and treatment of ocular diseases |
CN102614528B (zh) * | 2006-08-18 | 2014-02-26 | 箭头研究公司 | 用于体内递送多核苷酸的多缀合物 |
ITMI20080003A1 (it) * | 2008-01-02 | 2009-07-03 | Alfredo Pulpito | Composizioni per uso oftalmico |
US20090306579A1 (en) * | 2008-02-25 | 2009-12-10 | Eyegate Pharmaceuticals, Inc. | Delivery of corticosteroids through iontophoresis |
RU2519193C2 (ru) * | 2008-09-12 | 2014-06-10 | Критикал Фармасьютикалс Лимитед | Усовершенствование всасывания терапевтических средств через слизистые оболочки или кожу |
EP2349233A4 (en) * | 2008-10-09 | 2012-04-18 | Waratah Pharmaceuticals Inc | USE OF SCYLLO-INOSITOLS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH MACULAR DEGENERATION |
EP3524256A1 (en) * | 2009-08-24 | 2019-08-14 | Stealth Peptides International, Inc. | Methods and copositions for preventing or treating opthalmic conditions |
CN101836961B (zh) * | 2010-04-23 | 2012-05-30 | 天津大学 | 复合载药微球、盐酸米诺环素纳米缓释复合载药微球体系及其制备方法 |
US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
AU2011355093B2 (en) | 2011-01-12 | 2015-11-26 | Sooft Italia Spa | Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus |
JP2014503552A (ja) | 2011-01-12 | 2014-02-13 | ソーフト イタリア エスピーエー | 円錐角膜の処置のためのイオン導入による架橋剤の角膜送達および関連眼科組成物 |
US20140193466A1 (en) * | 2011-06-07 | 2014-07-10 | Cornell University | Silk compositions and methods of using same |
CN102579357B (zh) * | 2011-11-30 | 2013-05-22 | 天津大学 | 一种磁性复合载药微球及其制备方法 |
US9770419B2 (en) * | 2012-08-01 | 2017-09-26 | Shaker A. Mousa | Methods and compositions of camel derived products |
WO2014179344A1 (en) * | 2013-04-30 | 2014-11-06 | Massachusetts Institute Of Technology | Injectable nano-network gels for diabetes treatment |
-
2015
- 2015-12-21 WO PCT/US2015/067125 patent/WO2016100972A2/en active Application Filing
- 2015-12-21 BR BR112017012655-9A patent/BR112017012655B1/pt active IP Right Grant
- 2015-12-21 CN CN201580076497.8A patent/CN107249678B/zh active Active
- 2015-12-21 RU RU2017125496A patent/RU2706704C2/ru active
- 2015-12-21 US US14/977,048 patent/US10327946B2/en active Active
- 2015-12-21 EP EP15871275.2A patent/EP3233174B1/en active Active
- 2015-12-21 ES ES15871275T patent/ES2874562T3/es active Active
- 2015-12-21 PL PL15871275T patent/PL3233174T3/pl unknown
- 2015-12-21 JP JP2017532767A patent/JP2017538728A/ja active Pending
-
2019
- 2019-06-21 US US16/448,588 patent/US20190321221A1/en not_active Abandoned
-
2020
- 2020-04-17 JP JP2020073897A patent/JP6964708B2/ja active Active
-
2023
- 2023-06-20 US US18/211,886 patent/US20230329906A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2874562T3 (es) | 2021-11-05 |
RU2017125496A (ru) | 2019-01-21 |
RU2706704C2 (ru) | 2019-11-20 |
RU2017125496A3 (pl) | 2019-06-06 |
JP6964708B2 (ja) | 2021-11-10 |
EP3233174B1 (en) | 2021-03-31 |
US20230329906A1 (en) | 2023-10-19 |
EP3233174A2 (en) | 2017-10-25 |
JP2017538728A (ja) | 2017-12-28 |
WO2016100972A2 (en) | 2016-06-23 |
US20190321221A1 (en) | 2019-10-24 |
BR112017012655A2 (pt) | 2017-12-26 |
US10327946B2 (en) | 2019-06-25 |
US20160175148A1 (en) | 2016-06-23 |
BR112017012655B1 (pt) | 2022-11-01 |
WO2016100972A4 (en) | 2016-09-29 |
WO2016100972A3 (en) | 2016-08-11 |
EP3233174A4 (en) | 2018-08-01 |
JP2020121998A (ja) | 2020-08-13 |
CN107249678B (zh) | 2021-02-19 |
CN107249678A (zh) | 2017-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252839A0 (en) | Treatment of boils | |
ZA201702514B (en) | Motorized suprachoroidal injection of therapeutic agent | |
FI3851537T3 (fi) | Hyperbilirubinemian hoito | |
IL250677B (en) | Cancer treatment using anti-nkg2a agents | |
HK1246179A1 (zh) | 治療視網膜疾病的方法 | |
GB201701039D0 (en) | Vertically integrated continuous delivery of an application | |
HK1221558A1 (zh) | 生物醫學通電元素的生物相容性 | |
SG11201506309SA (en) | Eye massager | |
GB201403260D0 (en) | Treatment of retinal degeneration using gene therapy | |
PL3233174T3 (pl) | Wewnątrzgałkowe dostarczanie bioaktywnych cząsteczek za pomocą jontoforezy | |
EP3209331C0 (en) | EYE SOLUTION | |
ZA201704793B (en) | Treatment of retinal degeneration using progenitor cells | |
HK1205924A1 (en) | Eye massager | |
HK1231380A1 (zh) | 嚴重高甘油三酯血症的治療 | |
HK1244711A1 (zh) | Hmgb1介導的炎症的治療 | |
GB201410216D0 (en) | Therapeutic | |
GB201416832D0 (en) | Methods of treatment | |
GB201412578D0 (en) | Treatment of neurological diseases | |
EP3213762A4 (en) | Novel treatment of cornea using laminin | |
GB201419540D0 (en) | Delivery of drugs | |
GB201702738D0 (en) | Coordinated delivery of copd treatment | |
GB201415062D0 (en) | Therapeutic | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
GB201410507D0 (en) | Drug delivery enhancement agents | |
IL250637A0 (en) | Targeted release of hydrophilic drugs |